Large-scale skin cancer screening initiative feasible

February 25, 2017

(HealthDay)—Large-scale skin cancer screening, including full-body skin examination (FBSE) is feasible and increases diagnosis of melanoma and thinner invasive melanoma, according to a study published online Feb. 23 in JAMA Oncology.

Laura K. Ferris, M.D., Ph.D., from the University of Pittsburgh, and colleagues describe a screening initiative implemented in a large health care system among adults seen during an office visit with a University of Pittsburgh Medical Center-employed primary care physician. The intervention included implementation of a campaign promoting annual skin by FBSE.

The researchers found that 15.9 percent of the screen-eligible population of 333,735 adult received FBSE. Overall, 50 and 104 melanomas were diagnosed in screened and unscreened patients, respectively. Compared with unscreened patients, screened patients were more likely to be diagnosed with a melanoma (adjusted risk ratio, 2.4; 95 percent confidence interval, 1.7 to 3.4; P < 0.001) and to have a thinner invasive melanoma (median thickness, 0.37 versus 0.65 mm; P < 0.001). Screened and unscreened patients had similar incidence of melanoma lesions 1 mm or thicker (adjusted risk ratio, 0.7; 95 percent confidence interval, 0.2 to 2.2; P = 0.52).

"Large-scale screening for within a U.S. health care system is feasible and can result in increased detection of thinner melanomas," the authors write.

Several authors disclosed financial ties to the pharmaceutical industry.

Explore further: Early detection, smaller cancer among benefits of skin cancer screening at PCP visits

More information: Abstract/Full Text (subscription or payment may be required)

Related Stories

Early detection, smaller cancer among benefits of skin cancer screening at PCP visits

June 7, 2016
Skin cancer screenings performed by primary care physicians (PCPs) during routine office visits improve the detection of potentially deadly melanomas and find them in earlier stages, according to new research from the University ...

AAD: Older men should screen themselves for skin cancer

March 1, 2013
(HealthDay)—Men aged 50 years or older are more likely to be diagnosed with invasive melanoma by a dermatologist than to detect it themselves; and they are less likely to seek a skin cancer screening due to a suspicious ...

Personal history of prostate cancer linked to melanoma risk

November 6, 2013
(HealthDay)—History of prostate cancer (PCa) is associated with an increased risk of melanoma, according to a study published online Nov. 4 in the Journal of Clinical Oncology.

Dermatologist care tied to better self-detection of melanoma

April 25, 2014
(HealthDay)—Patients with self-detected primary melanoma who have an established dermatologist are more likely to have thinner lesions at the time of diagnosis, according to research published in the May issue of the Journal ...

Using clinical features to identify patients at high risk for melanoma

November 9, 2016
Can an individual's risk factors for melanoma be used to tailor skin self-examinations and surveillance programs? A new study published online by JAMA Dermatology suggests they could by identifying those patients at higher ...

Melanoma screening by physicians associated with finding more cancers than patient self-detection

July 18, 2011
Physician-based screening for melanoma is associated with higher rates of physician-detected melanoma and detection of thinner melanoma, according to a report published Online First today by Archives of Dermatology, one of ...

Recommended for you

Researchers discover specific tumor environment that triggers cells to metastasize

November 21, 2017
A team of bioengineers and bioinformaticians at the University of California San Diego have discovered how the environment surrounding a tumor can trigger metastatic behavior in cancer cells. Specifically, when tumor cells ...

New study points the way to therapy for rare cancer that targets the young

November 21, 2017
After years of rigorous research, a team of scientists has identified the genetic engine that drives a rare form of liver cancer. The findings offer prime targets for drugs to treat the usually lethal disease, fibrolamellar ...

Clinical trial suggests new cell therapy for relapsed leukemia patients

November 20, 2017
A significant proportion of children and young adults with treatment-resistant B-cell leukemia who participated in a small study achieved remission with the help of a new form of gene therapy, according to researchers at ...

Cell-weighing method could help doctors choose cancer drugs

November 20, 2017
Doctors have many drugs available to treat multiple myeloma, a type of blood cancer. However, there is no way to predict, by genetic markers or other means, how a patient will respond to a particular drug. This can lead to ...

Researchers discover a new target for 'triple-negative' breast cancer

November 20, 2017
So-called "triple-negative" breast cancer is a particularly aggressive and difficult-to-treat form. It accounts for only about 10 percent of breast cancer cases, but is responsible for about 25 percent of breast cancer fatalities.

Study reveals new mechanism used by cancer cells to disarm attacking immune cells

November 20, 2017
A new study by researchers at The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute (OSUCCC - James) identifies a substance released by pancreatic cancer cells that protects ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.